Purchase Order AG91H2P150064
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $5,363.55, is for the procurement of ROCHE 454 INSTRUMENT CHEMICALS AND CONSUMABLES. This award is not designated as a set-aside contract. Roche Diagnostics holds multiple significant Indefinite Delivery Contracts...
- This is a $3,118.40 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostic products. The contract is for the expansion of high fidelity enzyme blends for the amplification of genomic DNA targets. The contract has no set-aside designation, indicating it was competed openly. Roche Diagnostics is a global leader in diagnostic solutions...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which is a Blanket Purchase Agreement (BPA) call with a Firm Fixed Price (FFP) pricing type, has a ceiling value of $6,525.40 and was awarded on August 2, 2013 by the Office of the Chief Operating Officer, a civilian federal agency. The contract does not have a set-aside...
- This federal contract award was made by a civilian government agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The award is for the purchase of a Light Cycler 96 Instrument, with a ceiling value of $18,300.00. The contract is a firm fixed price purchase order without any set-aside designation, indicating open competition. Roche Diagnostics is a global leader...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products, to expand a high-fidelity PCR system for a large experiment requiring PCR amplification. The contract, with a ceiling value of $7,796.00, has a completion date of July 13, 2011. Roche Diagnostics is a global leader in diagnostic solutions, providing a wide...
- This federal contract award was made by the Office of the Director, a civilian federal agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $6,575.60 firm fixed price contract is a Blanket Purchase Agreement (BPA) call for DRUGS AND BIOLOGICALS, with a performance period ending on December 31, 2012. The contract does not have a set-aside designation,...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the procurement of Roche Diagnostic GS FLX Titanium Sequencing Kits. The $3,566.75 firm fixed price purchase order was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, with a period of performance ending on June 19, 2015. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics,...
- This federal contract award is to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The award, valued at $19,900.00, is for the purchase of a LightCycler 96 Instrument, including extended service coverage, LightCycler 480 Multiwell Plates, and FastStart Essential DNA Green Master reagents. The contract was awarded by the National Heart Lung and Blood Institute, a...
- This is a $9,734.40 firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has received numerous federal contract awards, including through General Services Administration (GSA) Schedule contracts,...
- This federal contract award was made by the Office of the Director, a civilian federal agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $14,454.30 firm fixed price contract is a Blanket Purchase Agreement (BPA) call for DRUGS AND BIOLOGICALS, with a performance period ending on December 31, 2012. The contract does not have a set-aside designation,...
This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract is for $6,333.81 and provides sequencing reagents and consumables for a GS 454 FLX+ Titanium DNA Sequencer. The contract has no set-aside designation, indicating Roche Diagnostics competed openly for this award. Roche Diagnostics is a global leader in diagnostic solutions and holds multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) across federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and National Institutes of Health, for a wide range of medical diagnostic technologies and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 6/19/15 |